Bacterial drug resistance has become a global public health threat, among which the
infection of carbapenem-resistant Enterobacterales (CRE) is one of the top noticeable …

Background Rapid and widespread increases in carbapenem resistance (CR) necessitate
identification of risk factors to guide appropriate interventions. Objectives We aimed to …

The spread of carbapenem-and polymyxin-resistant Enterobacteriaceae poses a significant
threat to public health, challenging clinicians worldwide with limited therapeutic options. This …

Background Background Greece is among the countries characterized by high rates of
antimicrobial resistance and high consumption of antibiotics, including carbapenems …

Carbapenem-resistant Enterobacteriaceae (CRE) have diminished treatment options
causing serious morbidities and mortalities. This systematic review and meta-analysis …

Antimicrobial chitosan–polyethylene oxide (CS-PEO) nanofibrous mats containing ZnO
nanoparticles (NPs) and hydrocortisone-imipenem/cilastatin-loaded ZnO NPs were …

Bacteria have evolved several strategies to survive a myriad of harmful conditions in the
environment and in hosts. In Gram-negative bacteria, responses to nutrient limitation …

Cefiderocol (CFDC) is a siderophore cephalosporin with activity against Gram-negative
bacterial species that are resistant to carbapenems and other drugs. The MICs of CFDC …

Enterobacteria-producing extended-spectrum β-lactamases (ESBL) play an important role in
healthcare infections, increasing hospitalization time, morbidity and mortality rates. Among …

Conventional antimicrobial susceptibility testing (AST) methods require 24–48 h to provide
results, creating the need for a probabilistic antibiotic therapy that increases the risk of …